Frontiers in oncology · 2026
Comparison of gene mutations of liver metastases to the primary tumor in colorectal cancer: lessons from a small cohort.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Rásó Erzsebet, Barbai Tamas, Vizkeleti Laura, Uhlyarik Andrea, Tímár József
Аннотация
INTRODUCTION: Upfront molecular diagnostics are used to characterize genetic features of colorectal cancer, guiding therapy. Since colorectal cancer is usually surgically resected, these samples are used for such characterizations. The extent to which liver metastases maintain the genetic profile of the primary tumor is a key question.
METHODS: Here, we used a small six-case pretreatment colorectal cancer cohort where targeted next-generation sequencing (NGS) was employed to compare liver metastases to the primary tumors.
RESULTS: We found, similar to previous reports, that the major genetic drivers are maintained in the liver metastases; however, changes at this level can still be detected. We also observed that in the majority of cases, the genetic profile of the primary tumor is partially or completely lost in liver metastases. On the other hand, we detected the metastasis-selective emergence of ABL1, HER2, RET, KIT, KDR, and VHL mutations.
DISCUSSION: Although our study is only hypothesis-generating, these data support the view that genetic analysis of colorectal cancer liver metastases may identify novel alterations compared to the primary tumors, which can be clinically exploited during disease management.
METHODS: Here, we used a small six-case pretreatment colorectal cancer cohort where targeted next-generation sequencing (NGS) was employed to compare liver metastases to the primary tumors.
RESULTS: We found, similar to previous reports, that the major genetic drivers are maintained in the liver metastases; however, changes at this level can still be detected. We also observed that in the majority of cases, the genetic profile of the primary tumor is partially or completely lost in liver metastases. On the other hand, we detected the metastasis-selective emergence of ABL1, HER2, RET, KIT, KDR, and VHL mutations.
DISCUSSION: Although our study is only hypothesis-generating, these data support the view that genetic analysis of colorectal cancer liver metastases may identify novel alterations compared to the primary tumors, which can be clinically exploited during disease management.